3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Pleural Effusion, Malignant
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
HIV Infections
1
Cervical Cancer Screening
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Zidovudine
3
Methotrexate
2
Leucovorin
2
Dexamethasone
2
fludarabine phosphate
1
X-Rays
1
Whole-Body Irradiation
1
Vincristine
1
Triage
1
Transurethral Resection of Prostate
1
Therapeutics
1
Tetanus Toxoid
1
Standard of Care
1
Smoking Devices
1
Semaxinib
1
Practice Guidelines as Topic
1
Pneumococcal Vaccines
1
Peripheral Blood Stem Cell Transplantation
1
Papillomavirus Vaccines
1
Papanicolaou Test
1
Mycophenolic Acid
1
Measles-Mumps-Rubella Vaccine
1
Massage
1
Mass Screening
1
Inosine Pranobex
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Heptavalent Pneumococcal Conjugate Vaccine
1
Hepatitis B Vaccines
1
Health Promotion
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
HIV Infections
×
Coal Tar
×
Clear all
NCT07225530
2026-02-25
(iSTAR)
Columbia University
Phase NA
Recruiting
600 enrolled